Harbor Capital Advisors Inc. Acquires 380,790 Shares of Evolent Health, Inc. (NYSE:EVH)

Harbor Capital Advisors Inc. lifted its stake in Evolent Health, Inc. (NYSE:EVH) by 90.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 803,211 shares of the technology company’s stock after acquiring an additional 380,790 shares during the period. Harbor Capital Advisors Inc. owned approximately 0.69% of Evolent Health worth $9,036,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Principal Financial Group Inc. increased its position in shares of Evolent Health by 3.2% during the second quarter. Principal Financial Group Inc. now owns 15,594 shares of the technology company’s stock valued at $298,000 after buying an additional 480 shares during the period. Rhumbline Advisers lifted its stake in Evolent Health by 8.3% in the 2nd quarter. Rhumbline Advisers now owns 180,059 shares of the technology company’s stock worth $3,443,000 after purchasing an additional 13,867 shares in the last quarter. Arizona State Retirement System grew its position in shares of Evolent Health by 2.3% during the 2nd quarter. Arizona State Retirement System now owns 29,083 shares of the technology company’s stock valued at $556,000 after purchasing an additional 649 shares in the last quarter. Quest Partners LLC purchased a new stake in shares of Evolent Health in the second quarter worth $87,000. Finally, Headlands Technologies LLC boosted its stake in Evolent Health by 2,369.9% during the second quarter. Headlands Technologies LLC now owns 34,850 shares of the technology company’s stock valued at $666,000 after buying an additional 33,439 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Oppenheimer decreased their target price on Evolent Health from $34.00 to $28.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. KeyCorp began coverage on shares of Evolent Health in a research note on Friday, October 11th. They issued an “overweight” rating and a $35.00 target price on the stock. JMP Securities cut their price target on shares of Evolent Health from $27.00 to $18.00 and set a “market outperform” rating for the company in a research note on Friday. Needham & Company LLC assumed coverage on shares of Evolent Health in a research report on Friday. They set a “buy” rating and a $15.00 price objective on the stock. Finally, Barclays cut their target price on shares of Evolent Health from $39.00 to $19.00 and set an “overweight” rating for the company in a research report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $24.17.

Evolent Health Trading Down 3.3 %

Shares of NYSE:EVH traded down $0.42 during midday trading on Friday, hitting $12.18. 583,130 shares of the stock traded hands, compared to its average volume of 1,314,679. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $1.42 billion, a PE ratio of -13.38 and a beta of 1.45. Evolent Health, Inc. has a one year low of $10.53 and a one year high of $35.00. The business’s 50 day moving average is $13.13 and its two-hundred day moving average is $21.09.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.